NASDAQ · LIJKX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 02:18 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock LifePath Index 2035 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock LifePath Index 2035 Fund’s forward annual dividend is $0.05 per share, paid semi-annual. The forward yield is 0.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund dynamically manages its portfolio by allocating and reallocating capital across a mix of underlying investment vehicles. These include index funds focused on equities and fixed income, as well as money market funds, with the distribution guided by the fund's comprehensive investment approach. Typically, at least 80% of its holdings will be invested in securities or other financial instruments that either directly constitute or possess economic attributes comparable to those found in its specific benchmark, known as the LifePath Index 2035 Fund Custom Benchmark.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$50.21+$0.76 (+1.54%)
Victory Sycamore Established Value Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
$46.69-$0.02 (-0.04%)
FPA Crescent Fund’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$30.60$0.00 (0.0%)
BlackRock LifePath Index 2050 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.42% below the high.
$27.44-$0.09 (-0.33%)
MFS Research International R2’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$25.55-$0.02 (-0.08%)
T. Rowe Price Retirement 2055 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
$28.54$0.00 (0.0%)
BlackRock LifePath Index 2045 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.26% below the high.
$60.51+$0.01 (+0.02%)
Hartford Core Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 1.63% below the high.
$67.74-$1.58 (-2.28%)
T. Rowe Price Science And Technology Fund’s quoted price sits in the upper half of its reported 52-week range, 19.13% below the high.
